Mason Street Advisors’s Integra LifeSciences IART Stock Holding History

Mason Street Advisors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-37,806	Closed	-$2.45M	–	569
2020 Q4	$2.45M	Sell	37,806 -81	-0.2%	-$4.36K	0.04%	512
2020 Q3	$1.79M	Sell	37,887 -703	-2%	-$33.4K	0.03%	576
2020 Q2	$1.81M	Buy	38,590 +683	+2%	+$33.6K	0.04%	556
2020 Q1	$1.69M	Hold	37,907	–	–	0.04%	505
2019 Q4	$2.21M	Buy	37,907 +676	+2%	+$40.2K	0.04%	539
2019 Q3	$2.24M	Sell	37,231 -585	-2%	-$34.9K	0.05%	499
2019 Q2	$2.11M	Buy	37,816 +198	+0.5%	+$10.2K	0.04%	532
2019 Q1	$2.1M	Buy	37,618 +585	+2%	+$29.8K	0.04%	550
2018 Q4	$1.67M	Buy	37,033 +742	+2%	+$40.7K	0.04%	566
2018 Q3	$2.39M	Buy	36,291 +111	+0.3%	+$6.9K	0.05%	454
2018 Q2	$2.33M	Buy	36,180 +18,546	+105%	+$1.15M	0.05%	465
2018 Q1	$976K	Buy	17,634 +1,101	+7%	+$57.7K	0.02%	846
2017 Q4	$791K	Buy	16,533 +516	+3%	+$25.3K	0.02%	905
2017 Q3	$809K	Buy	16,017 +1,098	+7%	+$56.4K	0.02%	889
2017 Q2	$813K	Buy	14,919 +941	+7%	+$44.9K	0.02%	872
2017 Q1	$589K	Buy	13,978 +906	+7%	+$38.7K	0.02%	936
2016 Q4	$561K	Buy	13,072 +766	+6%	+$31.1K	0.02%	938
2016 Q3	$508K	Buy	12,306 +956	+8%	+$40.1K	0.01%	931
2016 Q2	$453K	Buy	11,350 +1,090	+11%	+$39.2K	0.01%	933
2016 Q1	$346K	Buy	10,260 +962	+10%	+$30K	0.01%	972
2015 Q4	$315K	Buy	9,298 +918	+11%	+$28.7K	0.01%	969
2015 Q3	$250K	Sell	8,380 -190	-2%	-$5.94K	0.01%	1008
2015 Q2	$236K	Buy	8,570 +372	+5%	+$9.91K	0.01%	1031
2015 Q1	$207K	Buy	8,198 +252	+3%	+$5.96K	0.01%	1073
2014 Q4	$176K	Buy	7,946 +284	+4%	+$5.76K	﹤0.01%	1533
2014 Q3	$155K	Buy	7,662 +352	+5%	+$7.01K	﹤0.01%	1543
2014 Q2	$141K	Buy	7,310 +242	+3%	+$4.51K	﹤0.01%	1571
2014 Q1	$133K	Sell	7,068 -2,062	-23%	-$39.8K	﹤0.01%	1556
2013 Q4	$178K	Buy	9,130 +1,754	+24%	+$32.2K	﹤0.01%	1542
2013 Q3	$121K	Buy	7,376 +526	+8%	+$8.44K	﹤0.01%	1466
2013 Q2	$103K	Buy	+6,850	New	+$100K	﹤0.01%	1428

Other funds holding IART

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mason Street Advisors's IART Position: Q1 2021 in Review

Mason Street Advisors sold out of Integra LifeSciences (IART) in Q1 2021, closing a stake of 37,806 shares — an estimated $2.45M sold.

Mason Street Advisors first reported a position in IART in Q2 2013 and held it in 31 quarters. The position peaked at $2.45M in Q4 2020. 257 funds tracked by Wall St. Rank hold IART as of Q1 2021.

Mason Street Advisors reported no remaining Integra LifeSciences position as of Q1 2021 after selling out during the quarter.
Mason Street Advisors sold 37,806 Integra LifeSciences shares in Q1 2021, an estimated $2.45M.
Mason Street Advisors first reported a position in Integra LifeSciences in Q2 2013 and held it in 31 quarters.
Mason Street Advisors's Integra LifeSciences position peaked at $2.45M in Q4 2020.
257 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.